2012Unpublished venueRequires access

Glucose Abnormalities in Urban Hispanics: diagnosis, prevalence, risk predictive value, and association with metabolic syndrome and high blood pressure

Irene Hoffmanna, Anna Alfieria, Luigi Cubeddua

Open publisher page 0 citations

Abstract

The objective is to study the prevalence of glucose abnormalities (GA), their association with metabolic syndrome(MS), and the screening value of fasting plasma glucose (FPG) and insulin in detecting impaired glucose tolerance (IGT) and diabetes mellitus (DM), were determined in an unselected sample of apparently healthy Urban- Hispanics.OGGT was conducted in 592 subjects. GA were found in 34% of subjects, defined as impaired fasting glucose (IFG) (13.3%), IGT (6.9%), combined IFG+IGT (7.8%) and type2-DM (6.5%). FPG of 5.6-6.9mmol/l diagnostic of IFG missed 47.1% of subjects with IGT, and FPG >7.0mmol/l missed 53.9% of DM. GA were associated with abdominal obesity, hypertriglyceridemia, hyperinsulinemia, hypertension and MS. Prevalence of MS was greater in DM=IFG+IGT>IGT=IFG> controls. Post-load hyperinsulinemia and hyperglycemia was higher in IGT than in IFG; whereas HOMA-IR was higher in IFG. Indices of insulin secretion were markedly reduced in DM, IFG-IGT and IGT. In summary: currently recommended FPG thresholds detect only half of subjects with GA. Diagnosis of GA must include both, fasting and 2-hr postload glucose levels. Presence of fasting and post-load hyperglycemia-hyperinsulinemia in one individual mayexplain the increased risk in combined IFG-IGT and in DM. Because of its high prevalence, silent course, and associated increased risk, full-scale screening programs and aggressive management of GA must be implemented.

About this research paper

What this paper is about

The objective is to study the prevalence of glucose abnormalities (GA), their association with metabolic syndrome(MS), and the screening value of fasting plasma glucose (FPG) and insulin in detecting impaired glucose tolerance (IGT) and diabetes mellitus (DM), were determined in an unselected sample of apparently healthy Urban- Hispanics.OGGT was conducted in 592 subjects. GA were found in 34% of subjects, defined as impaired fasting glucose (IFG) (13.3%), IGT (6.9%), combined IFG+IGT (7.8%) and type2-DM (6.5%). FPG of 5.6-6.9mmol/l diagnostic of IFG missed 47.1% of subjects with IGT, and FPG >7.0mmol/l missed 53.9% of DM. GA were associated with abdominal obesity, hypertriglyceridemia, hyperinsulinemia, hypertension and MS. Prevalence of MS was greater in DM=IFG+IGT>IGT=IFG> controls. Post-load hyperinsulinemia and hyperglycemia was higher in IGT than in IFG; whereas HOMA-IR was higher in IFG. Indices of insulin secretion were markedly reduced in DM, IFG-IGT and IGT. In summary: currently recommended FPG thresholds detect only half of subjects with GA. Diagnosis of GA must include both, fasting and 2-hr postload glucose levels. Presence of fasting and post-load hyperglycemia-hyperinsulinemia in one individual mayexplain the increased risk in combined IFG-IGT and in DM. Because of its high prevalence, silent course, and associated increased risk, full-scale screening programs and aggressive management of GA must be implemented.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The objective is to study the prevalence of glucose abnormalities (GA), their association with metabolic syndrome(MS), and the screening value of fasting plasma glucose (FPG) and insulin in detecting impaired glucose tolerance (IGT) and diabetes mellitus (DM), were determined in an unselected sample of apparently healthy Urban- Hispanics.OGGT was conducted in 592 subjects. GA were found in 34% of subjects, defined as impaired fasting glucose (IFG) (13.3%), IGT (6.9%), combined IFG+IGT (7.8%) and type2-DM (6.5%). FPG of 5.6-6.9mmol/l diagnostic of IFG missed 47.1% of subjects with IGT, and FPG >7.0mmol/l missed 53.9% of DM. GA were associated with abdominal obesity, hypertriglyceridemia, hyperinsulinemia, hypertension and MS. Prevalence of MS was greater in DM=IFG+IGT>IGT=IFG> controls. Post-load hyperinsulinemia and hyperglycemia was higher in IGT than in IFG; whereas HOMA-IR was higher in IFG. Indices of insulin secretion were markedly reduced in DM, IFG-IGT and IGT. In summary: currently recommended FPG thresholds detect only half of subjects with GA. Diagnosis of GA must include both, fasting and 2-hr postload glucose levels. Presence of fasting and post-load hyperglycemia-hyperinsulinemia in one individual mayexplain the increased risk in combined IFG-IGT and in DM. Because of its high prevalence, silent course, and associated increased risk, full-scale screening programs and aggressive management of GA must be implemented.

Key concepts: Impaired fasting glucose, Impaired glucose tolerance, Internal medicine, Medicine, Hyperinsulinemia, Endocrinology, Metabolic syndrome, Diabetes mellitus

Related papers

Back to paper searchBrowse research topicsOriginal source
Glucose Abnormalities in Urban Hispanics: diagnosis, prevalence, risk predictive value, and association with metabolic syndrome and high blood pressure — Research Paper | ScholarLens